Medical principles and practice : international journal of the Kuwait University, Health Science Centre
-
This study was aimed at determining the distribution of type-specific human papillomavirus (HPV) in men with cutaneous warts and correlating this with the clinical and morphological presentation of warts. ⋯ This study shows that genus α HPV types are detected in about 82% of patients with cutaneous warts.
-
In this study, we describe ocular dirofilariasis in Bulgaria. ⋯ The most reliable and easily accessible diagnostic method is morphological analysis by microscopy of histological preparations of the parasite. In dirofilariasis, ocular location is the most common in humans, and it deserves special attention of clinicians.
-
The prevalence of acne vulgaris (AV) among adolescents in Kuwait has remained mostly unknown. This study aimed to estimate the prevalence of AV and its predictors among adolescents in Kuwait. ⋯ The prevalence of self-reported AV seems to be lower than that reported in other settings, while the prevalence of AV by clinical examination resembles that reported in many other countries. BMI was the only modifiable risk factor associated with AV in multivariable analysis, and none of the food items studied was related to the presence or absence of AV in multivariable analysis.
-
Randomized Controlled Trial
The Effect of Resin Infiltration on the Progression of Proximal Caries Lesions: A Randomized Clinical Trial.
The aim of this clinical trial was to assess the effect of resin infiltration on the progression of proximal caries lesions. ⋯ Resin infiltration of proximal caries lesions is effective in reducing progression of the lesion.
-
This study was aimed at evaluating the intravoxel incoherent motion (IVIM) parameter alterations of liver metastases of colorectal carcinoma (CRC) during antiangiogenic bevacizumab combination therapy. ⋯ IVIM parameters, particularly the perfusion fraction, may quantitatively reflect the response to antiangiogenic treatment. The antiangiogenic response manifests after 3 months of therapy before the RECIST-related response.